Opko Health, Inc. SEC filings OPK

Opko Health, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Sep 14, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFR14A Form defr14a Aug 30, 2024 —
NT 10-K Form nt 10-k Mar 1, 2024 Dec 31, 2023
UPLOAD Letter from the SEC Dec 26, 2018 —
CORRESP Letter to the SEC Dec 4, 2018 —
UPLOAD Letter from the SEC Nov 19, 2018 —
CORRESP Letter to the SEC Oct 11, 2018 —
CORRESP Letter to the SEC Oct 5, 2018 —
UPLOAD Letter from the SEC Sep 13, 2018 —
CORRESP Letter to the SEC Aug 17, 2018 —
UPLOAD Letter from the SEC Aug 3, 2018 —
CT ORDER Filing Apr 12, 2018 —
UPLOAD Letter from the SEC Oct 19, 2017 —
CORRESP Letter to the SEC Sep 25, 2017 —
UPLOAD Letter from the SEC Sep 14, 2017 —
SD Specialized disclosure (conflict minerals) Aug 30, 2017 —
CT ORDER Filing Sep 26, 2016 —

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OPK (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Miami, FL
SEC filer status
Accelerated filer
SEC CIK
944809
Former names
EXEGENICS INC (until Jun 13, 2007); eXegenics Inc (until Jun 13, 2007); CYTOCLONAL PHARMACEUTICS INC /DE (until Jun 4, 2001)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.